- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT07940465
PENG Block Versus Epidural Block for Postoperative Analgesia After Total Hip Arthroplasty
Evaluation of Pericapsular Nerve Group (PENG) Block and Epidural Block for Postoperative Analgesia Following Total Hip Arthroplasty: a Comparative Study
This study aims to compare the effectiveness of ultrasound-guided Pericapsular Nerve Group (PENG) block and epidural block for postoperative analgesia in patients undergoing elective unilateral total hip arthroplasty. A total of 62 eligible patients will be randomly allocated into two groups: Group A will receive epidural block, and Group B will receive PENG block. Postoperative pain scores, opioid consumption, time to first rescue analgesia, motor blockade, adverse effects, and time to mobilization will be assessed to compare the analgesic efficacy and recovery outcomes of the two techniques.
Panoramica dello studio
Stato
Intervento / Trattamento
Descrizione dettagliata
Postoperative pain management is an important component of recovery following total hip arthroplasty. Epidural analgesia is an established regional anesthesia technique, whereas ultrasound-guided Pericapsular Nerve Group (PENG) block is a newer technique intended to provide targeted analgesia to the hip joint.
This single-blind, randomized controlled trial will compare these two techniques in 62 patients undergoing elective unilateral total hip arthroplasty at Bangladesh Medical University, Dhaka, Bangladesh.
Participants will be randomly assigned in a 1:1 ratio to receive either an epidural block or a PENG block. Both groups will receive standardized postoperative multimodal analgesia. Pain intensity will be assessed using the Numeric Rating Scale (NRS) at 0, 2, 4, 6, 12 and 24 hours after surgery. Additional outcomes will include total opioid consumption, time to first rescue analgesia, motor blockade, adverse effects, and time to mobilization.
The findings will help compare the analgesic effectiveness and postoperative recovery associated with these two regional anesthesia techniques.
Tipo di studio
Iscrizione (Stimato)
Fase
- Non applicabile
Contatti e Sedi
Contatto studio
- Nome: Kazi Mahzabin Arin, MD
- Numero di telefono: 01754057689
- Email: kazimahzabinarin@bmu.ac.bd
Luoghi di studio
-
-
-
Dhaka, Bangladesh, 1000
- Bangladesh Medical University
-
Contatto:
- Kazi Mahzabin Arin, MD
- Numero di telefono: 01754057689
- Email: kazimahzabinarin@bmu.ac.bd
-
Investigatore principale:
- Suma Rani Paul
-
Sub-investigatore:
- Saiful Mahmud Tusher, FCPS
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Patients aged 18- 64 years, either sex
- Gender: Male and Female
- ASA physical status: I, II, or III
- Patients undergoing elective unilateral total hip arthroplasty
- Written informed consent obtained
Exclusion Criteria:
- Patient refusal to participate
- Known allergy to local anesthetics
- Infection at block site
- Coagulopathy (INR >1.5, Platelet <100,000/mm³)
- Neurological deficits in operated limb
- Chronic opioid use
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Separare
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Comparatore attivo: Group A
Participants will receive an epidural block before spinal anaesthesia using an 18G Tuohy needle at L2-L3 or L3-L4, followed by a test dose with 3 mL of 2% lidocaine with adrenaline and 15-20 mL of 0.25% bupivacaine. |
Participants will receive an epidural block before spinal anaesthesia using an 18G Tuohy needle at L2-L3 or L3-L4, followed by a test dose and 15-20 mL of 0.25% bupivacaine. |
|
Sperimentale: Group B
Participants will receive an ultrasound-guided PENG block in the supine position before spinal anaesthesia, using a 22-gauge needle and 20 mL of 0.25% bupivacaine. |
Participants will receive an ultrasound-guided Pericapsular Nerve Group Block (PENG) block before induction in the supine position, using a 22G needle and 20 mL of 0.25% bupivacaine. |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Postoperative pain score at rest and on movement using the Numeric Rating Scale (NRS)
Lasso di tempo: At the recovery room- 0, 2, 4, 6, 12 and 24 hours after surgery
|
Pain intensity will be assessed using a 10-cm Numeric Rating Scale (NRS). The scale ranges from 0 to 10 cm, where 0 cm indicates no pain and 10 cm indicates the worst imaginable pain. Higher scores indicate greater pain intensity. |
At the recovery room- 0, 2, 4, 6, 12 and 24 hours after surgery
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Time to First Rescue Analgesia
Lasso di tempo: Within 24 hours after surgery
|
Time from completion of surgery to the first administration of rescue analgesia (intravenous morphine 0.05 mg/kg when the Numeric Rating Scale pain score is 4 or higher). The time will be recorded in minutes. |
Within 24 hours after surgery
|
|
Total Opioid Consumption
Lasso di tempo: Time Frame: First 24 hours after surgery.
|
Total amount of intravenous morphine administered as rescue analgesia to each participant during the first 24 hours after surgery, measured in milligrams (mg).T |
Time Frame: First 24 hours after surgery.
|
|
Postoperative Motor Blockade
Lasso di tempo: At the recovery room- 0, 2, 6 hours after surgery
|
Motor blockade will be assessed using the Modified Bromage Scale, ranging from 0 to 3. A score of 0 indicates no motor block, while a score of 3 indicates complete motor block with inability to move the hip, knee, and ankle. Higher scores indicate greater motor blockade. |
At the recovery room- 0, 2, 6 hours after surgery
|
|
Postoperative Adverse Effects
Lasso di tempo: First 24 hours after surgery
|
Description: The occurrence of postoperative adverse effects, including hypotension, nausea, vomiting, and urinary retention, will be recorded for each participant. Each adverse effect will be documented as present or absent. |
First 24 hours after surgery
|
|
Time to First Mobilization
Lasso di tempo: Within 24 hours after surgery
|
Time from surgery completion until the participant first stands or walks. The time will be recorded in minutes. |
Within 24 hours after surgery
|
Collaboratori e investigatori
Sponsor
Pubblicazioni e link utili
Pubblicazioni generali
- Hawker GA, Mian S, Kendzerska T, French M. Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP). Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11:S240-52. doi: 10.1002/acr.20543. No abstract available.
- Giron-Arango L, Peng PWH, Chin KJ, Brull R, Perlas A. Pericapsular Nerve Group (PENG) Block for Hip Fracture. Reg Anesth Pain Med. 2018 Nov;43(8):859-863. doi: 10.1097/AAP.0000000000000847.
- Sloan M, Premkumar A, Sheth NP. Projected Volume of Primary Total Joint Arthroplasty in the U.S., 2014 to 2030. J Bone Joint Surg Am. 2018 Sep 5;100(17):1455-1460. doi: 10.2106/JBJS.17.01617.
- Kehlet H. Fast-track hip and knee arthroplasty. Lancet. 2013 May 11;381(9878):1600-2. doi: 10.1016/S0140-6736(13)61003-X. No abstract available.
- Pascarella G, Costa F, Del Buono R, Pulitano R, Strumia A, Piliego C, De Quattro E, Cataldo R, Agro FE, Carassiti M; collaborators. Impact of the pericapsular nerve group (PENG) block on postoperative analgesia and functional recovery following total hip arthroplasty: a randomised, observer-masked, controlled trial. Anaesthesia. 2021 Nov;76(11):1492-1498. doi: 10.1111/anae.15536. Epub 2021 Jul 1.
- Pai P, Amor D, Lai YH, Echevarria GC. Use and Clinical Relevancy of Pericapsular Nerve Block (PENG) in Total Hip Arthroplasty: A Systematic Review and Meta-analysis. Clin J Pain. 2024 May 1;40(5):320-332. doi: 10.1097/AJP.0000000000001196.
- Staikou C, Rekatsina M, Leoni MLG, Chamos C, Kapsokalyvas I, Varrassi G, Karmaniolou I. Efficacy and Safety of Pericapsular Nerve Group Block (PENG) in Hip Surgery Under General Anaesthesia: A Systematic Literature Review and Meta-Analysis. J Clin Med. 2025 Jan 13;14(2):468. doi: 10.3390/jcm14020468.
- Reysner T, Kowalski G, Mularski A, Reysner M, Wieczorowska-Tobis K. From Pain Control to Early Mobility: The Evolution of Regional Anesthesia in Geriatric Total Hip Arthroplasty. Reports (MDPI). 2025 May 9;8(2):64. doi: 10.3390/reports8020064.
- Pires Sousa I, Leite da Silva Peixoto CI, Fernandes Coimbra LA, da Costa Rodrigues FM. Comparison of pericapsular nerve group (PENG) block and epidural analgesia following total hip arthroplasty: A retrospective analysis. Rev Esp Anestesiol Reanim (Engl Ed). 2022 Dec;69(10):632-639. doi: 10.1016/j.redare.2022.10.002. Epub 2022 Nov 12.
- Lee KH, Wang JC, Chang CY, Teng WN, Wang HY, Lee CC, Tsai SW, Chen CF, Wu PK, Chen WM. Regional anaesthesia modalities for primary total hip arthroplasty: a systematic review and component network meta-analysis. Br J Anaesth. 2025 Aug;135(2):469-482. doi: 10.1016/j.bja.2025.04.019. Epub 2025 Jun 6.
- Evangelista T, Pugno C, Finazzi S, Colombi A, Bugada D. Regional anesthesia for hip surgery: A review of current approaches and their application to clinical practice. Saudi J Anaesth. 2025 Apr-Jun;19(2):164-173. doi: 10.4103/sja.sja_68_25. Epub 2025 Mar 25.
- de Souza DN, Lorentz NA, Charalambous L, Galetta M, Petrilli C, Rozell JC. Comprehensive Pain Management in Total Joint Arthroplasty: A Review of Contemporary Approaches. J Clin Med. 2024 Nov 13;13(22):6819. doi: 10.3390/jcm13226819.
Studiare le date dei record
Studia le date principali
Inizio studio (Stimato)
Completamento primario (Stimato)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- BMU/2026/20/000013
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .